Diisopropylethylamine → HCID 51354790, compound
Reaction equation
[C:1]1([C:7]#[C:8][C:9]2[S:10][C:11]([C:14]([OH:16])=O)=[CH:12][N:13]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.Cl.[F:18][C:19]1([F:25])[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]1.C1CN([P+](ON2N=NC3C=CC=CC2=3)(N2CCCC2)N2CCCC2)CC1.F[P-](F)(F)(F)(F)F.C(N(CC)C(C)C)(C)C>ClCCl>[F:18][C:19]1([F:25])[CH2:24][CH2:23][N:22]([C:14]([C:11]2[S:10][C:9]([C:8]#[C:7][C:1]3[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=3)=[N:13][CH:12]=2)=[O:16])[CH2:21][CH2:20]1Participants
Procedure
In a small culture tube, 2-phenylethynyl-thiazole-5-carboxylic acid (28 mg, 0.12 mmol) [Intermediate 1], 4,4-difluoropiperidine hydrochloride (23 mg, 0.14 mmol) (Oakwood Products, Inc. (West Columbia, S.C., USA) and dichloromethane (1.5 mL) were added. To the mixture, PyBOP® (76 mg, 0.14 mmol) was added, followed by N,N-diisopropylethylamine (63 μL, 0.36 mmol), and the reaction was stirred at room temperature for about 17 hours. Afterwards, the crude reaction mixture was directly purified by Preparative TLC, eluting with 40% EtOAc in hexanes to give 37 mg (92%) of the titled compound, (4,4-difluoro-piperidin-1-yl)-(2-phenylethynyl-thiazol-5-yl)-methanone, as a white solid. 1H NMR (300 MHz, CDCl3) δ 7.99 (s, 1H), 7.66-7.59 (m, 2H), 7.49-7.37 (m, 3H), 3.92-3.82 (m, 4H), 2.18-2.01 (m, 4H). LC/MS (Method 3), RT=1.43 min. Calculated [M+H]+=333; Observed [M+H]+=333.
Workup
- customAfterwards, the crude reaction mixture
- customwas directly purified by Preparative TLC
- washeluting with 40% EtOAc in hexanes
Sources & evidence
- ORD record
- ord-b6953dd68a2048948f0ee09361dc14d7
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08440837B2
Reaction notes
Loading…